Pitch Introduction
The PatchUp Shark Tank India pitch featured founder Radhika Rajpal, who introduced a disruptive health and wellness brand focused on transdermal nutrition. Tired of the sugar, preservatives, and additives found in traditional vitamin pills and gummies, Radhika developed a “peel and stick” solution that delivers nutrients directly through the skin.
Entering the tank with high energy, Radhika sought ₹50 Lakhs for 1.75% equity, valuing her company at ₹28.57 Crores. Her journey from being a high-flying consultant to a health-tech entrepreneur caught the immediate attention of the sharks, leading to a intense negotiation between the country’s top investors.
Business Overview
PatchUp is a Delhi-based health startup that offers vitamin patches designed to bypass the digestive system. Unlike traditional supplements that often lose potency during digestion, transdermal patches deliver active ingredients directly into the bloodstream through the skin.
The brand’s primary mission is to eliminate the “pill fatigue” experienced by many consumers while ensuring a clean label. The products are manufactured in an FD&C approved facility and are formulated without titanium dioxide, sugar, or synthetic colors, which are commonly found in Indian nutraceuticals.
Product Details
The current product lineup includes four specialized patches: Lean Up (for gut health and weight management), Rest Up (for sleep), Glow Up (for skin health), and Daily Up (multivitamins). The Lean Up patch is the hero product, featuring ingredients like Apple Cider Vinegar to help reduce sugar cravings, particularly for women with PCOD.
Market Position
PatchUp positions itself as a premium, science-backed alternative to the crowded gummy and pill market. While the category of transdermal supplements is relatively new in India, the brand targets health-conscious urban professionals and individuals over 40 who struggle with swallowing pills.
| Business Detail | Information |
|---|---|
| Company Name | PatchUp |
| Founder | Radhika Rajpal |
| Product Type | Transdermal Vitamin Patches |
| Price Range | ₹1,200 – ₹3,000 |
| Primary Channel | Direct-to-Consumer (D2C) & Marketplaces |
| Headquarters | Delhi, Delhi |
About Founder’s
Radhika Rajpal is a highly educated entrepreneur with a background in Economics from Lady Shri Ram College (LSR). Before starting PatchUp, she worked as an Associate Vice President at Barclays and later pursued an MBA from INSEAD. According to her Indian Express profile, she also worked with Booz & Co as a consultant.
- Radhika previously co-founded a startup called Beyond Equity but left due to personal reasons involving her co-founder ex-boyfriend.
- She spent significant time in Europe, where she realized that many supplements sold in India contained additives banned in the EU.
- She is an avid runner and fitness enthusiast who personally struggled with “pill fatigue.”
- The entire brand identity, logo, and product design were created by Radhika herself.
Shark’s and Founder’s QnA
Namita Thapar: In India, humidity and sweat often prevent patches from working. Why will you succeed where others failed?
We give four commandments for using our patches. The most important is to keep it away from sweat and water. We suggest users apply them at night because most people sleep in ACs now, and the patch needs 8 hours to work effectively. You put it on at 11 PM and take it off at 7 AM. It’s so light you don’t even feel it.
Anupam Mittal: You mentioned you left your previous startup because of an ex-boyfriend?
Yes, I started Beyond Equity in January 2022. I started it with one of my exes, and I eventually chose my mental health over that startup. I left nine months after our breakup because it was no longer a healthy environment. It was a difficult decision, but it led me back to India to solve a problem I’m passionate about.
Vineeta Singh: Are all supplements in India really full of harmful additives?
In my research, I couldn’t find a single major supplement brand that didn’t have something like titanium dioxide, which is a proven carcinogen in some studies. Manufacturers use these to make pills taste better or look a certain color. Because patches don’t need to be tasted, we can eliminate all those harmful additives.
Namita Thapar: Have you conducted clinical trials for these patches?
We have not done a full clinical trial yet. That is actually one of the main reasons I am here to raise funds. However, the formulation trials were done at the manufacturing stage. I understand that I need a more robust scientific team to scale this further.
Aman Gupta: The branding and packaging look very premium. Who did the design?
I did everything. From the colors to the logo and the overall brand identity, I designed it all myself. I wanted it to feel like a premium lifestyle product that people would be proud to keep on their bedside table.
Peyush Bansal: Why raise only ₹50 Lakhs? What is the goal?
This round is to build our initial inventory and start the clinical trials. By the end of this year, I plan to raise around half a million dollars (₹4 Crores approx) to expand our marketing and offline distribution. We already have a term sheet from Antler for ₹2 Crores at a ₹22 Crore valuation.
Key Stats & Financials
At the time of the pitch, PatchUp was in its early “hard launch” phase but showed impressive growth and unit economics. The brand operates with 90% gross margins, which is exceptionally high even for the supplement industry.
Revenue and Profitability
- August Sales: ₹5 Lakhs (Net Sales)
- September Sales (24 days): ₹12.5 Lakhs
- Gross Margin: 90%
- Projected FY Revenue: ₹1.5 Crores
- Burn: Minimal, with 10% EBITDA margin reported in early months
- Asks: ₹50 Lakhs for 1.75% Equity
Financial Breakdown
| Metric | Amount / Value |
|---|---|
| Monthly Sales (Sept) | ₹12.5 Lakhs |
| Monthly Sales (Aug) | ₹5 Lakhs |
| Marketing Spend (Aug) | ₹1 Lakh |
| Logistics & PG Fees | ₹2.1 Lakhs |
| COGS | ₹50,000 (on ₹5L sales) |
| Target Annual Revenue | ₹1.5 Crores |
Business Potential and TAM
The nutraceutical market in India is currently valued at approximately $4 Billion and is expected to reach $18 Billion by 2025. As Indian consumers become more health-conscious and wary of sugar-laden gummies, the demand for “clean label” supplements is skyrocketing. PatchUp sits at the intersection of health-tech and premium D2C beauty/wellness.
Market Size Analysis
The global transdermal drug delivery market is worth over $6 Billion, and while currently dominated by pain relief and nicotine patches, the transition into daily wellness supplements represents a massive opportunity. In India, the premium supplement segment (products priced above ₹1,000) is growing at a 25% CAGR as urban disposable incomes rise.
Growth Opportunities
- Clinical Validation: Conducting trials to prove efficacy will allow the brand to partner with dermatologists and nutritionists.
- Offline Expansion: Entering premium pharmacies and lifestyle stores like Guardian or Tira.
- Category Expansion: Launching specialized patches for hormonal balance (PCOS) and athletic recovery.
- Global Export: Leveraging the “Made in India” clean-label tag to sell in Western markets where patch technology is already accepted.
PatchUp: Ideal Target Audience & Demographics
| Demographic | Details |
|---|---|
| Primary Age Group | 25 – 45 years |
| Secondary Age Group | 45+ (Pill-fatigued seniors) |
| Interests | Biohacking, Fitness, Running, Skincare |
| Platform Preference | Instagram, LinkedIn |
| Geography | Tier 1 Cities (Mumbai, Delhi, Bangalore) |
| Buying Behavior | Subscription-based, Health-conscious |
Marketing and Distribution Strategy
PatchUp follows a digital-first approach, focusing heavily on educating the customer about transdermal benefits. Since the concept is new, the founder uses high-quality visual content to explain the “Peel, Stick, Feel” process.
Customer Acquisition
The brand currently acquires customers through Meta ads and organic LinkedIn content from the founder. With a marketing spend of ₹1 Lakh resulting in ₹5 Lakhs in sales, their initial ROAS (Return on Ad Spend) is a healthy 5x. The CAC is expected to stabilize as brand awareness grows.
Distribution Channels
- Own Website: High-margin D2C sales with subscription models.
- Amazon/Flipkart: Key for discoverability and trust.
- Quick Commerce: Plans to list on Zepto and Blinkit for instant gratification.
- B2B Partnerships: Collaborations with gym chains and wellness retreats.
Social Media and Content Strategy
Radhika uses her personal brand as an Ex-INSEAD consultant to build authority. The content strategy involves debunking myths about “hidden additives” in common foods and pills, positioning PatchUp as the only “pure” alternative.
PatchUp Shark Tank Deal Outcome
The pitch led to a battle between Peyush Bansal and Anupam Mittal. While Namita Thapar opted out due to a lack of clinical trials and Ritesh Agarwal felt the valuation was too steep, Anupam and Peyush both saw the founder’s potential.
| Shark | Offer Detail |
|---|---|
| Anupam Mittal | ₹50 Lakhs for 2.27% Equity (Matched Antler valuation) |
| Peyush Bansal | ₹50 Lakhs for 2.27% Equity OR ₹2 Crores for 10% |
| Ritesh Agarwal | ₹50 Lakhs for 5% Equity (Out later) |
| Vineeta Singh | Out (Concerned about category creation challenges) |
| Final Decision | Accepted Anupam Mittal’s offer of ₹50 Lakhs for 2.27% Equity |
PatchUp Post-Show Update
After the show, Radhika Rajpal clarified that she chose Anupam Mittal because of his deep understanding of the health and personal care space. According to a report by The Times of India, the brand has seen a significant surge in orders following the episode. Radhika mentioned that having an investor who aligns with her “clean label” passion is a blessing for the startup’s future.
Business Analysis & Lessons
PatchUp’s success on Shark Tank India was driven by the founder’s pedigree and the high gross margins of the product. At 90% margin, the business has enough room to spend on customer acquisition and education, which is critical for a new category. The “villain” in her story—harmful additives—was a compelling marketing angle that resonated with the health-conscious sharks.
However, the lack of clinical trials was a major hurdle. For any medical or health-related business, scientific backing is non-negotiable for long-term survival. The lesson here is that a great founder can sell a vision, but data and trials sell the product to the mass market.
Key Takeaways
- Founder Market Fit: Radhika’s educational background and personal struggle made her the perfect person to lead this brand.
- Category Creation: Being first in a new category (transdermal patches in India) allows for high valuations but requires massive educational marketing.
- Premium Positioning: High-end branding and packaging allowed the founder to justify a premium price point.
- Scientific Integrity: Claiming “trials” on packaging without full clinical data can lead to legal and reputational risks, as pointed out by Namita.
Pitch Conclusion
PatchUp Shark Tank India pitch was a masterclass in founder conviction and branding. By securing ₹50 Lakhs from Anupam Mittal, Radhika Rajpal has set the stage to revolutionize how Indians consume vitamins. If you enjoyed this breakdown, check out MeduLance, Matri, and CureSee.
[faq_accordian]